- Home
- XGN vs VRCA Comparison
XGN vs VRCA Comparison
Compare XGN & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- VRCA
- Stock Information
- Founded
- XGN 2002
- VRCA 2013
- Country
- XGN United States
- VRCA United States
- Employees
- XGN N/A
- VRCA N/A
- Industry
- XGN Medical Specialities
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- XGN Health Care
- VRCA Health Care
- Exchange
- XGN Nasdaq
- VRCA Nasdaq
- Market Cap
- XGN N/A
- VRCA 58.0M
- IPO Year
- XGN 2019
- VRCA 2018
- Fundamental
- Price
- XGN $3.84
- VRCA $0.43
- Analyst Decision
- XGN Strong Buy
- VRCA Hold
- Analyst Count
- XGN 2
- VRCA 5
- Target Price
- XGN $7.50
- VRCA $6.00
- AVG Volume (30 Days)
- XGN 101.8K
- VRCA 532.2K
- Earning Date
- XGN 03-11-2025
- VRCA 03-11-2025
- Dividend Yield
- XGN N/A
- VRCA N/A
- EPS Growth
- XGN N/A
- VRCA N/A
- EPS
- XGN N/A
- VRCA N/A
- Revenue
- XGN $55,641,000.00
- VRCA $7,566,000.00
- Revenue This Year
- XGN $20.54
- VRCA $93.38
- Revenue Next Year
- XGN $11.86
- VRCA $127.27
- P/E Ratio
- XGN N/A
- VRCA N/A
- Revenue Growth
- XGN 5.89
- VRCA 47.66
- 52 Week Low
- XGN $1.30
- VRCA $0.42
- 52 Week High
- XGN $6.22
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- XGN 51.79
- VRCA 29.54
- Support Level
- XGN $3.59
- VRCA $0.42
- Resistance Level
- XGN $4.58
- VRCA $0.66
- Average True Range (ATR)
- XGN 0.52
- VRCA 0.08
- MACD
- XGN 0.09
- VRCA -0.02
- Stochastic Oscillator
- XGN 58.43
- VRCA 5.26
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.